Responses
Original research
Effects of platelet glycoprotein IIb/IIIa receptor blockers in non-ST segment elevation acute coronary syndromes: benefit and harm in different age subgroups
Compose a Response to This Article
Other responses
Jump to comment:
- Published on: 27 June 2007
- Published on: 27 June 2007IIb/IIIa inhibition in the elderly: do they have a role after pre-treatment with clopidogrel?Show More
Dear Editor,
PRISM: ASA + heparin, ASA + tirofiban
PRISM-PLUS: ASA + heparin, ASA + heparin + tirofiban
PARAGON: ASA + heparin + lamifiban, ASA + lamifiban, ASA + heparin
PURSUIT: ASA + heparin, ASA + heparin + eptifibatide
GUSTO-IV ACS: ASA + heparin, ASA + heparin + abciximab
PARAGON-B: ASA + heparin, ASA + heparin + lamifiban
A meta-analysis by Hernandez...
Conflict of Interest:
None declared.